Medicare Advantage and the annual stress of picking a plan: AI promises help, but who does it work for?

By Zendoric · October 11, 2026.

Every year, between October 15 and December 7, tens of millions of older Americans repeat the same ritual: comparing Medicare Advantage plans, the private alternative that now covers more than half of the public program's beneficiaries. This week, just as enrollment season opens, the Pittsburgh Post-Gazette poses the question that a growing number of insurers, brokers and startups are trying to turn into a product: can artificial intelligence ease the burden of choosing among dozens of policies with different provider networks, copays and drug lists?

For industry context, the past two years have seen a proliferation of conversational assistants designed to summarize coverage brochures, compare out-of-pocket costs and flag whether a specific drug is on each plan's formulary. This is exactly the kind of task — sorting scattered, repetitive information — where a well-tuned language model delivers real, verifiable value in the short term, with no need for any spectacular AI breakthrough.

Our read is that the risk lies not in the technology but in who pays for it. An AI assistant funded by an insurer or a broker has a financial incentive to steer the recommendation toward the plan that generates the most commission, not the one that best fits the patient's health. That conflict of interest, more than the model's capability, is what any regulator or journalist covering this wave of tools should be scrutinizing.

In the long run, however, the use case fits the thesis we defend at Zendoric: handing AI the administrative and cognitive burden of complex bureaucratic decisions — precisely the ones that penalize older people most — is one of the most tangible ways technological abundance can translate into everyday well-being, long before AI's more ambitious promises in medicine arrive.